Skip to main content
. 2021 Jun 23;38(8):655–670. doi: 10.1007/s40266-021-00877-z

Table 3.

Diuretics used in the treatment of MD’s intercritical phase

Pharmacological class Activity Examples of drugs Side effects
Thiazides Inhibit reabsorption of luminal sodium by blocking the Na+/Cl channel in the kidney’s distal convoluted tubule

Chlorthalidone

Hydrochlorothiazide

Hypokalemia

Hyperuricemia

Hyperglycemia

Potassium-sparing diuretics Inhibit renal Na+/K+ exchange Spironolactone

Hyperkalemia

Hormonal alterations (estrogenic effects)

Loop diuretics Inhibit renal co-transport by blocking the Na+–K+–2Cl symporter Furosemide

Hypovolemia

Hypotension

Hypokalemia

Carbonic anhydrase inhibitors Inhibit H+ secretion and promote Na+ and K+ excretion Acetazolamide

Gastrointestinal disturbances

Metabolic acidosis

Nephrolithiasis

MD Ménière’s disease